Harvard researchers have published exciting results on a combination approach to tackling latent HIV. In a monkey model of HIV infection, the group combined the innate immune activating compound GS-9620 (a toll-like receptor 7 agonist) with the broadly neutralising antibody PGT121. The combination was given while infected monkeys were on treatment. When treatment stopped, the…
A promising study of a combination approach to HIV cure featured at last month’s Conference on Retroviruses and Opportunistic Infections in the US. The study looked at the impact of a broadly neutralising antibody (bNAb) together with an immune-activating compound in monkeys. Headed by Dan Barouch from the Beth Israel Deaconess Medical Center in Boston, the…
This beautiful photographic essay was compiled by The Alfred in Melbourne, and all credit for this article goes to their amazing teams and the people they care for. This article is shared with permission of The Alfred.
.png)
Working together with researchers and clinicians at The Alfred, members of the community of people living with HIV in Victoria have been integral to progressing ...
